Abstract
THE neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 promote the survival of subpopulations of vertebrate neurons in vitro, but so far only nerve growth factor has been demonstrated to be essential for normal neuronal development1–4; no neurotrophin has previously been shown to function in normal glial cell development. We found recently that neurotrophin-3 promotes the survival of pure oligodendrocyte precursor cells in vitro, and, although by itself it induces only a small percentage of these cells to synthesize DNA, in combination with platelet-derived growth factor it induces the majority of them to do so5. Neither of these factors, however, has been shown to contribute to oligodendrocyte precursor cell proliferation in vivo or to stimulate pure populations of these cells to proliferate (as opposed to synthesize DNA) in vitro. Here we show that neurotrophin-3 and platelet-derived growth factor collaborate to promote clonal expansion of oligodendrocyte precursor cells in vitro and to drive the intrinsic clock that times oligodendrocyte development6. We also show that neurotrophin-3 helps stimulate the proliferation of oligodendrocyte precursor cells in vivo and is thus required for normal oligodendrocyte development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hamburger, V., Brunsco-Bechtold, J. K. & Yip, J. W. J. Neurosci. 1, 60–71 (1981).
Hofer, M. M. & Barde, Y.-A. Nature 331, 261–262 (1988).
Cohen, S. Proc. natn. Acad. Sci. U.S.A. 46, 302–311 (1960).
Johnson, E. M. Jr, Gorin, P. M., Brandeis, L. D. & Pearson, J. Science 210, 916–918 (1980).
Barres, B. A., Schmid, R., Sendtner, M. & Raff, M. C. Development 118, 283–295 (1993).
Temple, S. & Raff, M. C. Cell 44, 773–779 (1986).
Raff, M. C., Abney, E. R. & Fok-Seang, J. Cell 42, 61–69 (1985).
Temple, S. & Raff, M. C. Nature 313, 223–225 (1985).
Barres, B. A. et al. Cell 70, 31–46 (1992).
Louis, J. C., Magal, E., Takayama, S. & Varon, S. Science 259, 689–692 (1993).
Richardson, W. C., Pringle, N., Mosley, M. J., Westermark, B. & Dubois-Dalcq, M. Cell 53, 309–319 (1988).
Noble, M., Murray, K., Stroobant, P., Waterfield, M. D. & Riddle, P. Nature 333, 560–562 (1988).
Elkabes, S., Schaar, D. G., Dreyfus, C. F. & Black, I. B. Abstr. Soc. Neurosci. 19, 251 (1993).
Merlio, J. P., Ernfors, P., Jaber, M. & Persson, H. Neuroscience 51, 513–32 (1992).
Chomcszynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Goblet, C., Prost, E., Bockhold, K. J. & Whalen, R. G. Meth. Enzym. 216, 160–168 (1992).
Barde, Y.-A. Prog. Growth Factor Res. 2, 237–48 (1990).
Bogler, O., Wren, D., Barnett, S., Land, H. & Noble, M. Proc. natn. Acad. Sci. U.S.A. 87, 6368–72 (1990).
McKinnon, R. D., Matsui, T., Dubois-Dalcq, M. & Aaronson, S. A. Neuron 5, 603–614 (1990).
Götz, R., Kolbeck, R., Lottspeich, F. & Barde, Y.-A. Eur. J. Biochem. 204, 745–749 (1992).
Magaud, J. P., Sargent, I. & Mason, D. Y. J. immun. Meth. 106, 95–100 (1988).
Raff, M. C., Miller, R. H. & Noble, M. Nature 303, 390–396 (1983).
Eisenbarth, G. S., Walsh, F. S. & Nirenburg, M. Proc. natn. Acad. Sci. U.S.A. 76, 4913–4916 (1979).
Ranscht, B., Clapshaw, P. A., Price, J., Noble, M. & Seifert, W. Proc. natn. Acad. Sci. U.S.A. 79, 2709–2713 (1982).
Gonchoroff, N. J., Greipp, P. R., Kyle, R. A. & Katzmann, J. A. Cytometry 6, 506–512 (1985).
Miller, R. H., David, S., Patel, R., Abney, E. R. & Raff, M. C. Devl Biol. 111, 35–41 (1985).
Schnell, L. & Schwab, M. E. Nature 343, 269–272 (1990).
Barres, B. A., Silverstein, B. E., Corey, D. P. & Chun, L. L. Y. Neuron 1, 791–803 (1988).
Barnstable, C. J. & Draeger, U. C. Neuroscience 11, 847–855 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barres, B., Raff, M., Gaese, F. et al. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367, 371–375 (1994). https://doi.org/10.1038/367371a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/367371a0
This article is cited by
-
Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro
Neurochemical Research (2020)
-
Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System
Molecular Neurobiology (2018)
-
Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment
Scientific Reports (2017)
-
Anosmin-1 over-expression regulates oligodendrocyte precursor cell proliferation, migration and myelin sheath thickness
Brain Structure and Function (2016)
-
Combination of Electroacupuncture and Grafted Mesenchymal Stem Cells Overexpressing TrkC Improves Remyelination and Function in Demyelinated Spinal Cord of Rats
Scientific Reports (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.